S Sloot1, J Van Nierop2, J J Kootstra3, C Wittens4, W M Fritschy5. 1. Department of General Surgery, University Medical Center, Groningen, the Netherlands. 2. Department of Cardiology, Diakonessenhuis, Utrecht, the Netherlands. 3. Department of Trauma Surgery, University Medical Center Groningen, the Netherlands. 4. Department of Vascular Surgery, UMC Maastricht, Maastricht, the Netherlands. 5. Department of Vascular Surgery, Isala Klinieken, Zwolle, the Netherlands w.m.fritschy@isala.nl.
Abstract
INTRODUCTION: Deep venous thrombosis treatment using catheter-directed thrombolysis is advocated over systemic thrombolysis because it reduces bleeding complications. With the development of a catheter that combines ultrasound vibrations and the local delivering of thrombolytics, new and safer treatments appear that are suitable for more complex problems. REPORT: An adolescent male presented with bilateral iliofemoral thrombosis based on a hypoplastic inferior vena cava that had existed for more than two weeks. He was successfully treated by bilateral ultrasound-accelerated catheter-directed thrombolysis using EkoSonic® (Small Vessel) Endovascular System (EKOS) and stenting of the inferior vena cava. After eight months of follow-up, the inferior vena cava is still patent. CONCLUSION: EKOS thrombolysis of longer existing bilateral deep venous thrombosis in the central venous system is a successful treatment modality in congenital inferior vena cava anomalies.
INTRODUCTION:Deep venous thrombosis treatment using catheter-directed thrombolysis is advocated over systemic thrombolysis because it reduces bleeding complications. With the development of a catheter that combines ultrasound vibrations and the local delivering of thrombolytics, new and safer treatments appear that are suitable for more complex problems. REPORT: An adolescent male presented with bilateral iliofemoral thrombosis based on a hypoplastic inferior vena cava that had existed for more than two weeks. He was successfully treated by bilateral ultrasound-accelerated catheter-directed thrombolysis using EkoSonic® (Small Vessel) Endovascular System (EKOS) and stenting of the inferior vena cava. After eight months of follow-up, the inferior vena cava is still patent. CONCLUSION: EKOS thrombolysis of longer existing bilateral deep venous thrombosis in the central venous system is a successful treatment modality in congenital inferior vena cava anomalies.